[1] Suthar
AB et al. Towards universal voluntary HIV
testing and counselling: a systematic review and meta-analysis of
community-based approaches. PLoS Medicine 10: e1001496, 2013.
[2]
Menzies N et al. The costs and
effectiveness of four HIV counseling and testing strategies in Uganda. AIDS
23(3):395-401, 2009.
[3] Kahn J
et al. Cost of community integrated
prevention campaign for malaria, HIV, and diarrhea in rural Kenya. BMC
Health Services Research 11:346, 2011.
[4] Van
den Berg H, Kelly-Hope LA, Lindsay SW Malaria
and lymphatic filariasis: the case for integrated vector management. Lancet
Infect Dis 13 (1): 89-94, 2013.
[5]
Modjarrod K, Vermund S Effect of
treating co-infections on HIV-1 viral load: a systematic review. Lancet
Infect Dis 10 (7): 455-463, 2010.
[6] Walson
JL, Herrin BR, John-Stewart G Deworming
helminth co-infected individuals for delaying HIV disease progression.
Cochrane Database of Systematic Reviews, 2009. DOI: 10.1002/14651858.CD006419.
[7] Gerens
HL, Sangaré LR, Walson JL Integration of
deworming into HIV care and treatment: a neglected opportunity. PLoS
Neglected Tropical Diseases 6 (7): e1738, 2012.
[8] Walson JL et al. Empiric deworming to delay HIV disease
progression in adults with HIV who are ineligible for initiation of
antiretroviral treatment (the HEAT study): a multi-site, randomised trial. Lancet Infectious Diseases 12 (12): 925-31, 2012.
[9] Ndeffo
Mbah ML et al. Cost-effectiveness of a
community-based intervention for reducing the transmission of Schistosoma
haematobium and HIV in Africa.
PNAS, epub ahead of print, 15 April 2013. doi: 10.1073/pnas.1221396110
[10] Kamya MR et al. Effect
of HIV-1 infection on antimalarial treatment outcomes in Uganda: a
population-based study. J Infect Dis 193(1):9-15, 2006.
[11] Patnaik P et al. Effects of HIV-1 serostatus, HIV-1
RNA concentration, and CD4 cell count on the incidence of malaria infection in
a cohort of adults in rural Malawi. J Infect Dis 192(6):984-91, 2005.
[12] Whitworth
J et al. Effect of HIV-1 and increasing
immunosuppression on malaria parasitaemia and clinical episodes in adults in
rural Uganda: a cohort study. Lancet 356(9235):1051-6, 2000.
[13] Ibid.
[14] Laufer
MK et al. Impact of HIV-associated immunosuppression on malaria
infection and disease in Malawi. J Infect Dis 193(6):872-8, 2006.
[15] Whitworth J et al. Effect of HIV-1 and increasing immunosuppression on malaria
parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.
Lancet 356:1051-56, 2000.
[16] French N et al. Increasing rates of malarial fever
with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 15: 899-906, 2001.
[17] Laufer MK et al. Impact of HIV-associated immunosuppression on malaria
infection on malaria infection and disease in Malawi.
J Infect Dis 193: 872-8, 2006.
[18] Cohen C et al. Increased prevalence of severe malaria in HIV-infected adults in South
Africa. Clin Infect Dis 41: 1631-7, 2005.
[19] Ter Kuile FO et al. The burden of co-infection with human immunodeficiency virus type 1 and
malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 71
(suppl 2) 41-54, 2004.
[20] Kalyesubula
I et al. Effect of malaria infection in human immunodeficiency virus
type-1-infected Ugandan children. Pediatr Infect Dis J 16:876-881, 1997.
[21] Malamba S et al. The effect of HIV on morbidity and mortality in children with severe
malarial anaemia. Malaria
Journal 6:143. doi:10.1186/1475-2875-6-143, 2007.
[22] Kublin JG et al. Effect of Plasmodium falciparum
malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a
prospective cohort study. Lancet 365(9455):233-40, 2005.
[23] Mermin
J, Lule J, Ekwaru J. Association between
malaria and CD4 cell count decline among persons with HIV. J Acquir Immune
Defic Syndr 41 (1): 129-30, 2006.
[24] Ter Kuile, op. cit.
[24] Walson JL et al. Evaluation of
impact of long-lasting insecticide-treated bed nets and point-of-use water
filters on HIV-1 disease progression in Kenya. AIDS (epub ahead of print,
16 Jan 2013).
[25] Mermin J et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell
count, and viral load in HIV infection in rural Uganda. AIDS
364(9443):1428-34, 2004.
[26] Campbell J et al. HIV-infected Ugandans on HAART with CD4 cell counts over 200 cells/mm3
who discontinue cotrimoxazole have increased risk of malaria and diarrhea.
2008 HIV Implementers’ Meeting, Kampala, Uganda, abstract number unlisted.
[27] Mermin J et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and
insecticide-treated bednets on the frequency of malaria in HIV-1-infected
adults in Uganda: a prospective cohort study. The Lancet 367(9518):1256-61,
2006.
[28] Kamya M et al. Effects of trimethoprim-sulfamethoxazole and insecticide-treated
bednets on malaria among HIV-infected Ugandan children. AIDS
21(15):2059-66, 2007.
[29] Brink AK et al. Diarrhea, CD4 counts and enteric infections
in a community-based cohort of HIV-infected adults in Uganda. J Infect 45(2):99-106, 2002.
[30] Lule JR et al. Effect of
home-based water chlorination and safe storage on diarrhea among persons with
human immunodeficiency virus in Uganda. Am J Trop Med Hyg 73(5):926-33,
2005.
[31] Peletz
R et al. Water, sanitation and hygiene
interventions to improve health among people living with HIV: a systematic
review. AIDS 27: 2593-2601, 2013.
[32]
Tulenko K, Bery R, Rosenbaum J. Analysis
of research on the effects of improved water, sanitation and hygiene on the
health of people living with HIV and AIDS and programmatic implications.
USAID Hygiene Improvement Project, 2007.
[33] Walson (2013), op. cit.
[34] Stern
AM, Markel H The history of vaccines and
immunization: familiar patterns, new challenges. Health Affairs 24 (3):
611-21, 2005.
[35]
Bygbjerg IB Double burden of
noncommunicable and infectious diseases in developing countries. Science
337 (6101): 1499-1501, 2012.
[36] Jeon
CY et al. Bi-directional screening for
tuberculosis and diabetes: a systematic review. Trop Med Int Health 15 (11): 1300-1314, 2010.
[37]
Verguet S et al. Cost savings associated with the provision of a simple care
package including long lasting insecticide treated bednets and a point-of-use
water filtration device to delay HIV-1 disease progression in Africa. 19th
International AIDS Conference, abstract MOPE768, Washington DC, 2012.
[38] Kern E
et al. Provision of bednets and water
filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan
multisite study. Trop Med Int Health (epub ahead of print, 2013).